Q1 EPS Estimates for PDS Biotechnology Increased by B. Riley

PDS Biotechnology Co. (NASDAQ:PDSB – Free Report) – Research analysts at B. Riley boosted their Q1 2025 EPS estimates for PDS Biotechnology in a research note issued to investors on Monday, April 21st. B. Riley analyst M. Mamtani now expects that the company will post earnings of ($0.31) per share for the quarter, up from […]

Leave a Reply

Your email address will not be published.

Previous post Q1 Earnings Estimate for SLDB Issued By Leerink Partnrs
Next post Analysts Set Plug Power Inc. (NASDAQ:PLUG) Target Price at $2.29